Literature DB >> 8903499

The pedicled omentoplasty and split skin graft (POSSG) for reconstruction of large chest wall defects. A validity study of 34 patients.

C M Contant1, A N van Geel, B van der Holt, T Wiggers.   

Abstract

The aim of this study was to evaluate retrospectively the results of pedicled omentoplasty and split skin graft (POSSG) in reconstructing (full thickness) chest wall defects, and to define its role as a palliative procedure for local symptom control. Thirty-four patients with recurrent breast cancer (n = 25), radiation-induced necrosis (n = 5) or sarcoma (n = 4) of the chest wall were selected for the study. All patients underwent curative or palliative chest wall resection with reconstruction by pedicled omentoplasty and split skin graft (POSSG), between 1986 and 1994. Reconstructive outcome, complications, local tumour and symptom control following surgery was measured. The most common complication was shown to be partial necrosis of the omental flap (35%), followed by respiratory problems (26%), facial hernia (26%) and thoracic wound problems (15%), which were mostly treated in a conservative way (68%). The 3-year local tumour-free interval after POSSG in patients curatively treated for breast cancer is 16%. Seventy per cent of the patients who underwent palliative resection had longstanding relief of local pain, bleeding or foetor due to local tumour growth. It can be concluded that large (full thickness) chest wall defects after resection of local recurrence, primary malignancy or osteoradionecrosis of the chest wall can successfully be reconstructed by POSSG. Chest wall resection in patients treated with palliative intention is effective in local symptom control.

Entities:  

Mesh:

Year:  1996        PMID: 8903499     DOI: 10.1016/s0748-7983(96)93143-1

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Utility of the omentum in the reconstruction of complex extraperitoneal wounds and defects: donor-site complications in 135 patients from 1975 to 2000.

Authors:  C Scott Hultman; Grant W Carlson; Albert Losken; Glyn Jones; John Culbertson; Gregory Mackay; John Bostwick; M J Jurkiewicz
Journal:  Ann Surg       Date:  2002-06       Impact factor: 12.969

2.  Pedicled full-thickness abdominal flap combined with skin grafting for the reconstruction of anterior chest wall defect following major electrical burn.

Authors:  Jing-Chun Zhao; Chun-Jing Xian; Jia-Ao Yu; Kai Shi
Journal:  Int Wound J       Date:  2013-03-13       Impact factor: 3.315

3.  Laparoscopically harvested omental flap: results for 96 patients.

Authors:  Hisamitsu Zaha; Susumu Inamine
Journal:  Surg Endosc       Date:  2009-06-04       Impact factor: 4.584

4.  Pedicled omental split skin graft: A novel method for reconstruction of full-thickness abdominal wall defect.

Authors:  Anindya Chattopadhyay; Sumitra Kumar Biswas; Meghnad Dutta
Journal:  J Indian Assoc Pediatr Surg       Date:  2010-10

5.  Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: analysis of prognostic factors.

Authors:  Albertus N van Geel; Michel W J M Wouters; Titia E Lans; Paul I M Schmitz; Cornelis Verhoef
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

6.  Deep sternal wound infection after open heart surgery: current treatment insights. A retrospective study of 36 cases.

Authors:  Rutger M Schols; Thomas M A S Lauwers; Gijs G Geskes; René R W J van der Hulst
Journal:  Eur J Plast Surg       Date:  2011-04-12

Review 7.  Curative use of forequarter amputation for recurrent breast cancer over an axillary area: a case report and literature review.

Authors:  Chun-Hao Tsai; Huey-En Tzeng; Wei-Kae Juang; Pei-Guo Chu; Patricia Fann; Yi-Chin Fong; Horng-Chaung Hsu; Yun Yen
Journal:  World J Surg Oncol       Date:  2014-11-18       Impact factor: 2.754

8.  Prognostic factors in 77 curative chest wall resections for isolated breast cancer recurrence.

Authors:  Carmen C van der Pol; Albertus N van Geel; Marian B E Menke-Pluymers; Paul I M Schmitz; Titia E Lans
Journal:  Ann Surg Oncol       Date:  2009-12       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.